Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-08 16:53 |
6K:Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Can…
|
English | 148.5 KB | ||
| 2020-09-08 16:53 |
6K:Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Can…
|
English | 36.5 KB | ||
| 2020-09-08 16:14 |
Received a notification letter from Nasdaq stating that the Company has regaine…
|
English | 85.2 KB | ||
| 2020-09-08 16:14 |
Received a notification letter from Nasdaq stating that the Company has regaine…
|
English | 36.5 KB | ||
| 2020-09-08 15:51 |
Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219
|
English | 121.7 KB | ||
| 2020-09-08 15:51 |
Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219
|
English | 36.6 KB | ||
| 2020-09-06 10:41 |
Receives Notice of Intention to Grant Two Patents in China Covering Company’s L…
|
English | 116.3 KB | ||
| 2020-09-06 10:41 |
Receives Notice of Intention to Grant Two Patents in China Covering Company’s L…
|
English | 36.7 KB | ||
| 2020-08-17 15:35 |
Amended and Restated Articles of Association;
Amended and Restated Memorandum …
|
English | 488.3 KB | ||
| 2020-08-17 15:35 |
Amended and Restated Articles of Association;
Amended and Restated Memorandum …
|
English | 36.2 KB | ||
| 2020-08-13 10:49 |
The Company will change the ratio of its American
Depositary Shares to ordinar…
|
English | 97.7 KB | ||
| 2020-08-13 10:49 |
The Company will change the ratio of its American
Depositary Shares to ordinar…
|
English | 36.5 KB | ||
| 2020-08-11 17:35 |
Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Re…
|
English | 535.7 KB | ||
| 2020-08-11 17:35 |
Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Re…
|
English | 36.8 KB | ||
| 2020-08-11 16:50 |
Provides Corporate Update and Reports First Half 2020 Financial
|
English | 199.4 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
